1. Home
  2. SFBS vs OGN Comparison

SFBS vs OGN Comparison

Compare SFBS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ServisFirst Bancshares Inc.

SFBS

ServisFirst Bancshares Inc.

HOLD

Current Price

$38.69

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.75

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SFBS
OGN
Founded
2005
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SFBS
OGN
Price
$38.69
$13.75
Analyst Decision
Buy
Hold
Analyst Count
3
5
Target Price
★ $46.33
$11.25
AVG Volume (30 Days)
590.0K
★ 1.9M
Earning Date
10-19-2026
11-09-2026
Dividend Yield
★ 1.93%
0.58%
EPS Growth
★ 21.63
N/A
EPS
★ 3.09
0.95
Revenue
N/A
★ $6,216,000,000.00
Revenue This Year
$20.42
N/A
Revenue Next Year
$9.87
$2.51
P/E Ratio
★ $12.72
$14.48
Revenue Growth
★ N/A
N/A
52 Week Low
$37.51
$5.69
52 Week High
$92.08
$13.83

Technical Indicators

Market Signals
Indicator
SFBS
OGN
Relative Strength Index (RSI) 31.00 50.65
Support Level $37.51 $13.46
Resistance Level $88.63 $13.77
Average True Range (ATR) 0.93 0.04
MACD 0.88 -0.00
Stochastic Oscillator 38.88 26.92

Price Performance

Historical Comparison
SFBS
OGN

About SFBS ServisFirst Bancshares Inc.

Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary. Through the subsidiary, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: